What are the primary indicators that my hybridoma cell line requires rescue?

Look for reduced viability post-thaw, a noticeable decline in antibody production, or signs of contamination. Slow growth, altered cell morphology, or an increasing proportion of non-producing cells also signal a need for intervention to restore health and function.

Is it possible to rescue a hybridoma if only a very small number of viable cells remain?

Yes, our advanced enrichment technologies are designed for challenging samples, including those with extremely low viable cell counts. Techniques like FACS and LEAP precisely isolate even a handful of healthy, antibody-producing cells, greatly increasing recovery chances.

Can you help with long-term storage of my rescued hybridoma cell line?

Absolutely. After successful rescue and expansion, we offer comprehensive cryopreservation services. We assist in preparing certified working cell stocks and master cell banks, ensuring secure, stable storage for your valuable clones for future use.

Will my rescued hybridoma cell line maintain its original antibody specificity and productivity?

Preserving original characteristics is our priority. Through meticulous enrichment and re-cloning, we aim to restore both specificity and robust productivity. Rigorous quality control confirms these attributes post-rescue, ensuring confidence in the recovered cell line.

How does your Hybridoma Enrichment Service differ from standard cell culture recovery?

Our service uses advanced technologies like FACS, microfluidics, and LEAP to precisely isolate viable, antibody-producing cells. This targeted approach significantly enhances re-cloning and expansion success rates, offering a distinct advantage over conventional bulk culture methods.

Which enrichment technology should I choose for my hybridoma rescue?

The optimal enrichment technology depends on your specific hybridoma's condition, the desired purity, and downstream applications. FACS offers high-throughput sorting based on fluorescent markers, suitable for diverse applications. Droplet-based microfluidics excels in ultra-sensitive, gentle isolation of individual cells, ideal for fragile or low-density cultures. LEAP provides image-guided, non-contact selection for precise recovery of rare cells. Our experts will consult with you to recommend the most suitable method for your unique project.

What deliverables can we expect to receive after the hybridoma rescue service?

Upon successful completion of the hybridoma rescue service, you will receive a revived and expanded hybridoma cell line, ready for your research or production needs. Key deliverables typically include cryopreserved vials of the rescued hybridoma, comprehensive data reports detailing viability, growth characteristics, and antibody productivity post-rescue. We also provide quality control documentation, including mycoplasma test results, ensuring the purity and stability of the cell line.

Hybridoma Enrichment Service

Overview Service Features FAQ

At Creative Biolabs, we specialize in rescuing compromised hybridoma cell lines through our advanced Hybridoma Enrichment Service. Leveraging years of expertise, we precisely isolate viable, antibody-producing cells, restoring your valuable research assets. Our commitment is to deliver unparalleled purity and productivity, ensuring your projects advance without interruption.

Overview of Hybridoma Enrichment

Hybridoma enrichment is a critical process for revitalizing cell lines that have lost viability, productivity, or become contaminated. Often, valuable hybridoma cultures can degrade due to factors like improper freezing, genetic instability, or overgrowth by non-producing cells. Without effectively concentrating the healthy, antibody-secreting cells, subsequent attempts at re-culturing or re-cloning are frequently unsuccessful, leading to wasted time and resources. This targeted purification step is essential for establishing a robust starting population. By selectively recovering the active hybridomas, we significantly boost the chances of successful downstream applications. We employ cutting-edge technologies, including advanced cell sorting and microfluidic platforms, to achieve exceptional purity and maintain cell integrity throughout this vital process. This strategic intervention ensures only the most vigorous and productive cells are carried forward, maximizing the potential for sustained antibody production and long-term cell line stability.

Hybridoma Enrichment Service

Hybridoma Enrichment by Fluorescence-Activated Cell Sorting (FACS)

FACS stands as a premier technique for isolating specific cell populations with high precision. This method involves labeling hybridoma cells with fluorescent markers that bind to indicators of viability or antibody production. As individual cells stream through a laser, their unique fluorescent signatures are detected, allowing for rapid and accurate sorting.

At Creative Biolabs, our state-of-the-art FACS systems are operated by highly skilled technicians. We meticulously develop and refine gating strategies to identify and recover only the most robust, antibody-secreting clones, effectively separating them from non-producers, dead cells, and cellular debris. This rigorous approach ensures unparalleled purity and viability in the enriched cell population, establishing an optimal foundation for successful re-cloning and expansion.

Fig.1 FACS screening. (He, Meifang, et al., 2015) Fig.1 Procedures for FACS analysis of heterotypic CICs.¹

Droplet-Based Microfluidics Enrichment

Droplet-based microfluidics offers an innovative approach to single-cell analysis and enrichment, encapsulating individual cells within minute picoliter-volume droplets. This technology facilitates high-throughput screening and sorting of hybridomas in isolated, controlled micro-environments, thereby minimizing cross-contamination and preserving cellular integrity. Each droplet functions as a self-contained bioreactor, enabling precise monitoring of individual cell characteristics, such as antibody secretion rates, and facilitating the rapid identification of superior-producing clones.

We leverage cutting-edge droplet-based microfluidic systems for ultra-sensitive enrichment. Our specialists design bespoke assays within these micro-environments to pinpoint and sort hybridomas exhibiting exceptional antibody production and robust growth characteristics. This novel method provides an incredibly gentle yet highly effective means of enriching even the most delicate hybridoma cell lines, ensuring maximum recovery of valuable clones for your critical projects.

Laser-Enabled Analysis and Processing (LEAP) Enrichment

LEAP represents an advanced, image-guided cell selection technology that enables the non-contact isolation of single cells directly from a heterogeneous mixture. This sophisticated method employs high-resolution imaging to analyze individual cells for desired phenotypic traits, including morphology, viability, or specific fluorescent markers. Following identification, a precisely targeted laser pulse gently guides the selected cell into a designated collection well. LEAP offers exceptional precision and minimal cellular stress, making it particularly suitable for fragile hybridoma cells.

At Creative Biolabs, our implementation of LEAP technology provides an unmatched level of specificity and control in hybridoma enrichment. We are capable of identifying and isolating rare, high-value antibody-producing cells with exquisite accuracy, even from severely compromised or low-density cultures. This highly targeted approach ensures the recovery of truly monoclonal and highly productive hybridomas, significantly enhancing the success rates of challenging rescue operations and accelerating the establishment of stable cell lines.

Features of Our Service

Decades of Expertise: Benefit from our extensive experience in hybridoma cell line development and rescue, ensuring knowledgeable and effective solutions.
Cutting-Edge Technology: We deploy advanced platforms like FACS, droplet microfluidics, and LEAP for superior purity and recovery of valuable clones.
Customized Rescue Strategies: Each project receives a tailored approach, optimizing protocols to meet the unique needs of your specific hybridoma cell line.
Rigorous Quality Assurance: Comprehensive quality control measures are integrated throughout the process, guaranteeing stable and reliable rescued cell lines.
Efficiency and Cost-Effectiveness: Our streamlined services provide rapid turnaround times, reducing your project timelines and overall operational costs.

FAQ

Q: What are the primary indicators that my hybridoma cell line requires rescue?
A: Look for reduced viability post-thaw, a noticeable decline in antibody production, or signs of contamination. Slow growth, altered cell morphology, or an increasing proportion of non-producing cells also signal a need for intervention to restore health and function.
Q: Is it possible to rescue a hybridoma if only a very small number of viable cells remain?
A: Yes, our advanced enrichment technologies are designed for challenging samples, including those with extremely low viable cell counts. Techniques like FACS and LEAP precisely isolate even a handful of healthy, antibody-producing cells, greatly increasing recovery chances.
Q: Can you help with long-term storage of my rescued hybridoma cell line?
A: Absolutely. After successful rescue and expansion, we offer comprehensive cryopreservation services. We assist in preparing certified working cell stocks and master cell banks, ensuring secure, stable storage for your valuable clones for future use.
Q: Will my rescued hybridoma cell line maintain its original antibody specificity and productivity?
A: Preserving original characteristics is our priority. Through meticulous enrichment and re-cloning, we aim to restore both specificity and robust productivity. Rigorous quality control confirms these attributes post-rescue, ensuring confidence in the recovered cell line.
Q: How does your Hybridoma Enrichment Service differ from standard cell culture recovery?
A: Our service uses advanced technologies like FACS, microfluidics, and LEAP to precisely isolate viable, antibody-producing cells. This targeted approach significantly enhances re-cloning and expansion success rates, offering a distinct advantage over conventional bulk culture methods.
Q: Which enrichment technology should I choose for my hybridoma rescue?
A: The optimal enrichment technology depends on your specific hybridoma's condition, the desired purity, and downstream applications. FACS offers high-throughput sorting based on fluorescent markers, suitable for diverse applications. Droplet-based microfluidics excels in ultra-sensitive, gentle isolation of individual cells, ideal for fragile or low-density cultures. LEAP provides image-guided, non-contact selection for precise recovery of rare cells. Our experts will consult with you to recommend the most suitable method for your unique project.
Q: What deliverables can we expect to receive after the hybridoma rescue service?
A: Upon successful completion of the hybridoma rescue service, you will receive a revived and expanded hybridoma cell line, ready for your research or production needs. Key deliverables typically include cryopreserved vials of the rescued hybridoma, comprehensive data reports detailing viability, growth characteristics, and antibody productivity post-rescue. We also provide quality control documentation, including mycoplasma test results, ensuring the purity and stability of the cell line.

In addition to the hybridoma enrichment services shown above, multiple hybridoma rescue services and comprehensive monoclonal antibody preparation services are also available at Creative Biolabs. Our experienced team is willing to share the key considerations for hybridoma enrichment and empower your research with our advanced hybridoma platforms. If you are interested in our hybridoma enrichment services, please contact us for more details.

Reference

He, Meifang, et al. "Fluorescence-activated cell sorting analysis of heterotypic cell-in-cell structures." Scientific Reports 5.1 (2015): 9588.
Distributed under Open Access license CC BY 4.0, without modification.

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

	USA: Europe: Germany:
	Call us at: USA: UK: Germany:
	Fax:
	Email: